- High expectations for the achievement of key milestones, including sales wins at major quick service restaurants (QSRs) and food processors.
- Favorable FDA and USDA consideration of new "direct food contact" products will increase market opportunity.
- The Company will soon turn the corner for its long-awaited, SDC antimicrobial technology platform to achieve commercial viability. This will have an immediate upward impact on share prices.
- The risk-to-reward ratio has tipped in favor of buying shares now, at prices under $1.50, versus waiting for breaking news and paying higher prices per share.